Stapled hemorrhoidopexy height as outcome indicator
Presented at the 49th Annual Meeting of the Midwest Surgical Association, Mackinac Island, MI, August 6–9, 2006
Received 12 August 2006; received in revised form 20 September 2006
Abstract
Background
Postoperative expectations after stapled hemorrhoidopexy are still being clarified. Our purpose was to evaluate how outcome is affected by staple line height (SLH) above the dentate line and specimen histology.
Methods
A prospective database identified demographics, SLH, histology, narcotic use, return to work, and resolution or recurrence of preoperative symptoms data for analysis.
Results
One hundred five patients were analyzed; median age was 49 years. Median RTW and narcotic use were 9 and 4 days, respectively. Patients with squamous epithelium–containing specimens had longer narcotic use (P = .038), whereas patients with SLH >20 mm had shorter narcotic use (P = .021). Preoperative pain and bleeding resolved more frequently with SLH >20 mm (P = .036) and less frequently with SLH >40 mm (P = .032). Patients with poor sphincter tone were more likely to have SLH >20 mm (P = .044). Postoperative symptoms recurred more frequently in patients with SLH >40 mm (P = .001).
Conclusions
Hemorrhoidopexy SLH and histology can impact postoperative outcomes. SLH should be >20 mm yet ≤40 mm above the dentate, avoiding squamous epithelium.
ABSTRACT